Rigel Pharmaceuticals (RIGL) Beats Q2 Earnings Estimates by $0.71
Earnings Results Rigel Pharmaceuticals (NASDAQ:RIGL) reported quarterly earnings results on August 04, 2026 that exceeded analyst expectations. The Healthcare company reported…
Read more
